MXCT | MaxCyte, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.97 - 4.12
52 Week Range	3.17 - 5.55
Beta	1.56
Implied Volatility	126.14%
IV Rank	53.64%
Day's Volume	198,848
Average Volume	528,161
Shares Outstanding	105,482,560
Market Cap	433,533,322
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2021-07-30

Valuation
Profitability
Growth
Health
P/E Ratio	-12.09
Forward P/E Ratio	N/A
EPS	-0.34
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	143
Country	USA
Website	MXCT

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.

MXCT's peers: CERS, SGHT, CVRX, NPCE, RPID, CNMD, KIDS, SRDX, ITGR, LUNG, IRMD, OFIX, OSA, ANIK, HSKA, PAVM, QTRX, RBOT

*Chart delayed

Analyzing fundamentals for MXCT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see MXCT Fundamentals page.

Watching at MXCT technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on MXCT Technicals page.